The Cytokine Storm Company

Lenzilumab, COVID-19, and Cytokine Storm

Q&A Series

About Us

We are a clinical stage biopharmaceutical company, developing our immunology and immuno-oncology portfolio of monoclonal antibodies. We are focusing our efforts on the development of our lead product candidate, lenzilumab, our proprietary Humaneered® (“Humaneered”) anti-human granulocyte-macrophage colony-stimulating factor (“GM-CSF”) monoclonal antibody.

AdobeStock_203971424.jpeg

"The more original a discovery the more obvious it seems afterwards."

Arthur Koestler

Follow Us

  • Twitter
  • LinkedIn
  • Facebook

©2021 Humanigen, Inc.  All rights reserved